Lactose Intolerance Treatment Market Size, Share & Trends Analysis Report By Type (Primary Lactose Intolerance, Secondary Lactose Intolerance, Congenital/Developmental Lactose Intolerance, By Treatment), Food Supplements (Enzyme Lactase Supplements, Probiotics, Others), By Form (Tablet/Capsule, Powder, Liquid), By End-User (Hospitals and Clinics, Home Care) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Lactose Intolerance Treatment Market Size

The global lactose intolerance treatment market size was valued at USD 39.49 billion in 2025 and is projected to grow from USD 42.24 billion in 2026 to USD 72.42 billion by 2034, registering a CAGR of 6.97% during the forecast period from 2026 to 2034. America dominated the lactose intolerance treatment market with a market share of 38.2% in 2025.

There is a rising prevalence of lactose intolerance worldwide, driven by factors such as changing dietary habits, ethnic predispositions, and better awareness leading to improved diagnosis. This trend directly increases the demand for lactose intolerance treatments.

Lactose intolerance is a digestive problem with an impaired ability to digest lactose. Primary lactase deficiency, secondary lactase deficiency, congenital lactase deficiency, and developmental lactase deficiency are the four different kinds of lactose intolerance identified. Irritable bowel syndrome (IBS), gastroenteritis, Crohn's disease, ulcerative colitis, celiac disease, chemotherapy, and medications are the leading causes of secondary lactase insufficiency. The symptoms of lactose intolerance may include flatulence, diarrhea, bloated stomach, stomach cramps and pains, stomach rumbling, and others.

Type Insights

The primary lactose intolerance segment is responsible for the largest market share and is anticipated to grow at a CAGR of 6.13% over the forecast period. Primary lactose intolerance refers to a condition in which the body cannot digest a sugar called lactose in dairy products. Usually, the body produces an enzyme called lactase that breaks down this sugar, but certain conditions, such as illness or injury, cause the small intestine to produce less lactase. Globally, about 70% of the lactose intolerant population is suffering from a primary type of lactose intolerance, per the clinical report published by the American Academy of Pediatrics (AAP) 2018.

Congenital lactose intolerance is the life-long absence of lactase enzyme in the body. This condition happens at birth. Generally, this condition is scarce in babies as nearly all infants have the enzyme that breaks down lactose. Developmental lactose intolerance (neonatal) is a condition that occurs in premature infants. Generally, this condition is temporary, and the situation improves as an individual develops. This lactose intolerance treatment includes removing and substituting lactose from the diet with commercial lactose-free formula.

Request Customizationto receive a tailored report.

Treatment Insights

The global lactose intolerance treatment market is segmented into food supplements, enzyme lactase supplements, probiotics, and others.

The food supplements segment is the highest contributor to the market and is expected to grow at a CAGR of 6.16% over the forecast period. Food supplements for lactose intolerance refer to dairy products free from lactose, such as lactose-free milk, lactose-free chocolates, and other dairy-related products. Dietary Guidelines for Americans 2015–2020 advise lactose intolerant people to consume dairy products like yogurt and hard cheese because they contain less lactose than ordinary milk. In addition, supermarkets can offer lactose-free or reduced milk and milk products. They are identical to regular milk except that the lactase enzyme has been added, resulting in a slightly sweeter taste than regular milk. Health professionals also recommend soymilk and other products for lactose intolerance.

Probiotics are live microorganisms that, when administered adequately, confer a health benefit on the host. Probiotics also give the gut a helping hand in digesting lactose. It can reduce lactose concentration in fermented products such as yogurt and increase the activity of the enzyme which breaks down lactose. In addition, the market growth of the probiotics segment is due to the growing accessibility to advanced internet facilities in developed and developing regions of the world. Moreover, the increasing adoption of internet facilities for purchasing supplements is expected to contribute to the segment's market growth.

Form Insights

The global lactose intolerance treatment market is segmented into tablet/capsule, powder, and liquid.

The powder segment owns the highest market share and is expected to grow at a CAGR of 5.96% over the forecast period. Using lactose-free and lactose-reduced powder products may help to lower the amount of lactose in the diet. These products are available in many grocery stores and are just as healthy as regular milk and other dairy products. Generally, most of the powder products in the lactose intolerance treatment market are for children suffering from lactose intolerance. Hence, the primary consumers of this market are children and parents. Parents must be worried about lactose-intolerant children and teenagers getting enough calcium in a diet that includes little to no milk because milk and other dairy products are a key source of calcium.

Lactose is often used as an excipient in tablets because of its ideal characteristics. Most patients with lactose intolerance tolerate small amounts of lactose. But the population consuming tablet/capsule for the treatment of lactose intolerance is very low, as people prefer home remedies or other substitutes such as lactose-free milk, coffee, chocolates, and others more than tablets/capsules. Tablets of lactase may be taken when ingesting milk and dairy products. Further, the lactase enzyme breaks down the food's lactose. Using lactase tablets can help to prevent the symptoms of lactose intolerance. However, comparative studies have shown that these solid lactase preparations, in capsules and tablets, are more expensive and significantly less effective than pre-hydrolyzed milk, probably due to gastric enzyme inactivation.

End-User Insights

The global lactose intolerance treatment market is segmented into hospitals and clinics and home care.

The home care segment is the highest contributor to the market and is expected to grow at a CAGR of 6.24% over the forecast period. Home care is the leading segment because the products or drugs sold for lactose intolerance treatment are nonprescriptive. Therefore, it is easy for buyers to look for lactose-free or lactose-intolerant products. Also, many companies have started selling lactose-intolerant products, a significant aid for people suffering from lactose intolerance. They do not need to go to hospitals and clinics to buy those products, as they are available in retail stores and e-commerce websites.

The hospitals and clinics segment is growing due to many people carrying out medical treatments involving lactase enzymes, which helps the market's growth. Clinics are also medical care centers that provide care for particular therapeutic areas. If the intake of lactose-containing food is removed from the diet and the symptoms continue, a doctor would recommend supplementing the diet with nonprescription lactase enzyme tablets or drops. In addition, avoiding milk and dairy products may mean lactose-intolerant people require calcium and vitamin D supplements. This share is majorly attributed to the increasing number of patients monitored with lactose intolerance disorder. Hospitals are one of the key users of supplements due to many people carrying out medical treatments.

Speak to an Analystto discuss market opportunities.

Regional Insights

Americas is the most significant shareholder in the global lactose intolerance treatment market and is anticipated to grow at a CAGR of 6.62%during the forecast period. The Americas is further segmented into North and Latin America. The consumption of dairy products is also distinct and variable in the Americas.

• For instance, one of the world's fastest-growing dairy markets is in Latin America. Furthermore, customers in this area are seeking more practical ways to shop. They seek to purchase products from a single location or store, and it is one of the main drivers of hypermarkets and supermarkets in Latin America. However, the lower purchasing power of consumers is creating high fluctuation in prices and causing consumers to cut back and seek discounted deals.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Lactose Intolerance Treatment Market Trends

Asia-Pacific is expected to grow at a CAGR of 7.31% over the forecast period. Asia-Pacific is the second-largest region and fastest-growing in the lactose intolerance treatment market. In terms of value, it has the most significant dairy consumption. However, it has the lowest per capita income spent on dairy products as it is still developing better infrastructure for distributing chilled dairy products. The growth driver of this region is the rise of modern trade, changing consumer habits, and dynamic product development.

Additionally, the region's fast industrialization and the growth of the food and beverage industry, particularly in China, India, and Vietnam, have created new market prospects for the Asia-Pacific region. In contrast to Denmark, where just 2% of adults have lactose intolerance, estimations indicate that 80% of individuals in Central Asia and 90% to 100% of adults in East Asia have lactose intolerance. Since most Asians lack lactase, there will undoubtedly be a rise in demand for lactose-free dairy products, which will help the business expand.

Europe Market Trends

Europe is the third-largest region in the lactose intolerance treatment market. Dairy consumption in Western Europe is reasonable compared to other regions of Europe and has a high per-capita consumption rate throughout the region. According to Euromonitor International, Western European dairy sales dropped between 2012 and 2017 by USD 3.6 billion. Despite this decline, there are some growth possibilities for dairy products in the Western Europe market, as it has continued fluctuation between categories and continued premiumization. Due to the presence of a well-developed food and beverage processing industry, there is a strong demand for dairy enzymes in Europe. Furthermore, the primary drivers influencing the regional market are technical improvements and the presence of essential European producers, like DSM and Chr. Hansen Holding A/S. A more optimistic view on nutrition and health has increased the region's per-capita cost of lactase-based dietary supplements.

The Middle East and Africa is expected to grow steadily during the forecast period. The world's lowest dairy spending per capita, at just USD 25, is found in the Middle East and Africa, two highly obsolete regions. The producers find it quite challenging to contact their customers due to the region's inadequate infrastructure system. However, the market's growth will be even more dynamic if the affordability rate improves.

List of Key and Emerging Players in Lactose Intolerance Treatment Market